The use of psychedelics like LSD, psilocybin, mescaline and DMT is associated with a significant decrease in illicit opioid consumption, according to a new study.<\/p>\n
Researchers looked at data from \u201cthree harmonized prospective cohorts of community-recruited\u201d people with substance misuse disorders. A total of 3,813 individuals were involved, including 1,093 who reported illicit opioid consumption and 229 who said they\u2019d used psychedelics in the past six months.<\/p>\n
\u201cRecent psychedelic use was associated with 55% reduced odds of daily opioid use,\u201d the Vancouver-based study, published last week in the Journal of International Drug Policy, found.<\/p>\n
While there have been numerous studies connecting legal marijuana access to reduced opioid use and fewer overdose deaths, this is \u201cthe first longitudinal study to link psychedelic use with lower daily opioid use,\u201d the paper says.<\/p>\n
\u201cOver study follow-up after adjusting for a range of potential confounders, psychedelic use remained independently associated with a significantly reduced odds of subsequent daily opioid use,\u201d the study states. \u201cWhile confirmation in other settings is required, these findings align with growing evidence that psychedelic use may be associated with detectable reductions in subsequent substance use including illicit opioid use.\u201d<\/p>\n
While there\u2019s not a clear explanation for the trend\u2014and the researchers urged additional studies\u2014psychedelics like psilocybin and MDMA have been touted as potentially powerful tools in mental health treatment, effectively treating conditions like severe depression, post-traumatic stress disorder and addiction.<\/p>\n
\u201cThese findings align with growing evidence demonstrating that psychedelic use may be associated with detectable reductions in subsequent opioid use, and warrant further research on psychedelics for opioid and other substance use disorders,\u201d the study\u2019s lead author, Elena Argento of the University of British Columbia, told Marijuana Moment.<\/p>\n
\u201cThis study found naturalistic psychedelic use to be independently associated with a significantly reduced odds of subsequent daily illicit opioid use among a community-based sample of [people who use drugs],\u201d the study<\/a> concluded. \u201cMore research with controlled trials and longer-term follow-up is required to elucidate the therapeutic potential of psychedelics to augment existing interventions for substance use disorders, including among more diverse populations. Additional qualitative studies would also provide opportunities to improve understanding of the possible psycho-social mechanisms underpinning psychedelic experiences.\u201d<\/p>\n Another recent study found that when people use cannabis together with psychedelics<\/a>, it was \u201cassociated with higher scores of mystical-type experience, ego-dissolution and visual alterations.\u201d<\/p>\n With respect to marijuana alone, a study published earlier this year found that cannabis use is associated with significant reductions in dependence on opioids<\/a> and other prescription drugs, as well as an increase in quality of life<\/p>\n Another study released last year determined that states with active medical marijuana laws saw certain opioid prescription rates drop nearly 20 percent compared to prohibition states<\/a>.<\/p>\n Using Marijuana With Psychedelics Intensifies The Mystical Experience, Study Finds<\/a><\/p>\n<\/blockquote>\n\n Photo elements courtesy of carlosemmaskype<\/a> and Apollo<\/a>.<\/em><\/p>\n The post Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds<\/a> appeared first on Marijuana Moment<\/a>.<\/p>\n
The use of psychedelics like LSD, psilocybin, mescaline and DMT is associated with a significant decrease in illicit opioid consumption, according to a new study. Researchers looked at data from \u201cthree harmonized prospective cohorts of community-recruited\u201d people with substance misuse disorders. A total of 3,813 individuals were involved, including 1,093Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":458,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[15462],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/51173"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/458"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=51173"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/51173\/revisions"}],"predecessor-version":[{"id":51174,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/51173\/revisions\/51174"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=51173"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=51173"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=51173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\n
\nRead More: Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"